Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neurogene Inc. | Director | Stock Option (Right to Buy) | 7.7K | Jun 14, 2024 | Direct | ||
Mosaic ImmunoEngineering Inc. | Director | Convertible Note | $50K | Feb 18, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NGNE | Neurogene Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
NGNE | Neurogene Inc. | Jan 16, 2024 | 1 | $0 | 4 | Jan 18, 2024 | Director |
NGNE | Neurogene Inc. | Dec 18, 2023 | 0 | $0 | 3 | Dec 26, 2023 | Director |
CPMV | Mosaic ImmunoEngineering Inc. | Feb 18, 2022 | 1 | $50K | 4 | Feb 22, 2022 | Director |
CPMV | Mosaic ImmunoEngineering Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 16, 2021 | Director |